Open AccessPhase 1 Dose-Ranging Safety Trial of Lactobacillus crispatus CTV-05 for the Prevention of Bacterial Vaginosis
Author(s) -
Anke Hemmerling,
W. G. Harrison,
Adrienne Schroeder,
Jeanna Park,
Abner P. Korn,
Stephen Shiboski,
Craig R. Cohen
Publication year - 2009
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e3181a74924
Subject(s) - bacterial vaginosis , medicine , lactobacillus crispatus , dose ranging study , microbiology and biotechnology , lactobacillus , vaginal flora , gynecology , bacteria , pathology , double blind , placebo , alternative medicine , biology , genetics
Bacterial vaginosis is a very common vaginal infection. The lack of endogenous lactobacilli and overgrowth of pathogens facilitate numerous gynecological complications.